🔎 Trials Near Me

መነሻ › ሉፑስ ኔፍራይቲስ › New York

በNew York ለሉፑስ ኔፍራይቲስ የሚደረጉ ክሊኒካዊ ጥናቶች

ለሉፑስ ኔፍራይቲስ የሚደረጉ 16 ጥናቶች በNew York ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በNew York ውስጥ ያሉ ከተሞች

Official study text (English)

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

  • Stony Brook Internists PC, East Setauket
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05268289

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

  • Circuit Clinical, Orchard Park
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06711887

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

  • New York Medical College, Hawthorne
  • NorthWell, New Hyde Park
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ16 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07328581

VIBRANT: VIB4920 for Active Lupus Nephritis

  • Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases, Manhasset
  • Hospital for Special Surgery, New York: Division of Rheumatology, New York
  • Columbia University Medical Center: Department of Medicine, Division of Rheumatology, New York
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT05201469

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

  • Hospital for Special Surgery, New York
  • Children's Hospital at Montefiore, New York
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ8 እስከ 20 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT05538208

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

  • Research Site, New York
  • Research Site, Syracuse
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06897930

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Icahn School of Medicine at Mount Sinai, New York
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT07085104

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

  • Cohen Children's Medical Center of New York, Queens
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ5 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT05039619

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • University of Rochester, Rochester
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06121297

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

  • Icahn School of Medicine at Mount Sinai, New York
  • State University of New York Upstate Medical Center (SUNY), Syracuse
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ12 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT07053800

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

  • Buffalo Rheumatology and Medicine, PLLC, Orchard Park
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT07611214

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

  • Nkarta Investigational Site, New York
  • Nkarta Investigational Site, Stony Brook
  • Nkarta Investigational Site, Syracuse
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT06557265

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • Montefiore Medical Center, New York
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ12 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT06308978

Lupus Landmark Study: A Prospective Registry and Biorepository

  • The Feinstein Institutes for Medical Research, Manhasset
  • Columbia University Medical Center, New York
  • Northwell Health, New York
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 110 · ሁሉም ጾታዎች · የተሻሻለው በ15 ኤፕሪ 2026 · NCT05934149

Safety and Efficacy of ONT01 in Lupus

  • Hospital for Special Surgery, New York
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኖቬም 2025 · NCT07107659

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

  • The Rogosin Institute, New York
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኤፕሪ 2025 · NCT01802034

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።